Take home messages Incorporation of novel agents into the treatment paradigms for fit patients with newly diagnosed multiple myeloma has led to a remarkable increase in the rates of complete response and minimal residual disease negative status, ultimately translating into near tripling of median overall survival of this disease. In frail individuals who cannot tolerate multi-drug combinations treatment goals include improvement in the quality of life and avoidance of early treatment discontinuation due to drug toxicities.
Cavo M., Tacchetti P., Zamagni E. (2019). Front-line treatment of multiple myeloma. HEMASPHERE, 3(2), 127-130 [10.1097/HS9.0000000000000242].
Front-line treatment of multiple myeloma
Cavo M.;Tacchetti P.;Zamagni E.
2019
Abstract
Take home messages Incorporation of novel agents into the treatment paradigms for fit patients with newly diagnosed multiple myeloma has led to a remarkable increase in the rates of complete response and minimal residual disease negative status, ultimately translating into near tripling of median overall survival of this disease. In frail individuals who cannot tolerate multi-drug combinations treatment goals include improvement in the quality of life and avoidance of early treatment discontinuation due to drug toxicities.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
